SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA)PRNewsWire · 3 days ago
B. Riley Wealth Advisors Inc. Makes New $546,000 Investment in STAAR Surgical Company $STAADefense World · Oct 17, 2026
STAAR Surgical Names Andrew Pilon as Vice President of Business DevelopmentGuruFocus · Oct 8, 2026
STAAR Surgical Names Andrew Pilon as Vice President of Business DevelopmentBusiness Wire · Oct 8, 2026
Why Staar Surgical Zoomed Almost 8% Higher on TuesdayThe Motley Fool · Sep 29, 2026
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For TuesdayBenzinga · Sep 29, 2026STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 12, 2026 | $0.22 | $0.16 | Miss |
| May 13, 2026 | $0.05 | $0.38 | Beat |
| Mar 3, 2026 | $0.18 | -$0.20 | Miss |
| Nov 5, 2025 | $0.18 | $0.46 | Beat |
| Aug 6, 2025 | -$0.56 | -$0.34 | Beat |
| May 7, 2025 | -$0.59 | -$0.52 | Beat |